美国 - 英文 - NLM (National Library of Medicine)

washington homeopathic products - chamomilla 6c, coffea cruda 6c, hyoscyamus 6c, ignatia 6c, nux vomica 6c, passiflora 6c - eases insomnia caused by grief, intense mental application and stress. is a natural sleep aid that is non-habit forming. will not cause drowsiness and has no side effects. indications: chamomilla irritability coffea cruda sleeplessness hyoscyamus twitching ignatia sadness nux vomica vomiting passiflora insomnia if symptoms persist/worsen or if pregnant/nursing, stop use and consult your practitioner. *claims based on traditional homeopathic practice, not accepted medical evidence. not fda evaluated.

美国 - 英文 - NLM (National Library of Medicine)

silver star brands, inc - equisetum arvense top (unii: 1dp6y6b65z) (equisetum arvense top - unii:1dp6y6b65z) - equisetum arvense top 6 [hp_c] in 19 g - reduces bedwetting and nervousness in children uses: homeopathic remedy for bedwetting in children and teens

美国 - 英文 - NLM (National Library of Medicine)

nivagen pharmaceuticals, inc. - drospirenone (unii: n295j34a25) (drospirenone - unii:n295j34a25), ethinyl estradiol (unii: 423d2t571u) (ethinyl estradiol - unii:423d2t571u) - drospirenone 3 mg - drospirenone and ethinyl estradiol tablets are indicated for use by women to prevent pregnancy. do not prescribe drospirenone and ethinyl estradiol tablets to women who are known to have the following: - renal impairment - adrenal insufficiency - a high risk of arterial or venous thrombotic diseases. examples include women who are known to: smoke, if over age 35[see boxed warning and warnings and precautions (5.1)] have deep vein thrombosis or pulmonary embolism, now or in the past[see warnings and precautions (5.1)] have cerebrovascular disease[see warnings and precautions (5.1)] have coronary artery disease[see warnings and precautions (5.1)] have thrombogenic valvular or thrombogenic rhythm diseases of the heart (for example, subacute bacterial endocarditis with valvular disease, or atrial fibrillation)[see warnings and precautions (5.1)] have inherited or acquired hypercoagulopathies[see warnings and precautions (5.1)] have uncontrolled hypertension[see warnings and precautions (5.5)] have d

美国 - 英文 - NLM (National Library of Medicine)

boehringer ingelheim pharmaceuticals inc. - bisacodyl (unii: 10x0709y6i) (deacetylbisacodyl - unii:r09078e41y) - bisacodyl 5 mg - use - for temporary relief of occasional constipation and irregularity - this product generally produces bowel movement in 6 to 12 hours stop use and ask a doctor if - you have rectal bleeding or no bowel movement after using this product. these could be signs of a serious condition. - you need to use a laxative for more than 1 week

美国 - 英文 - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - mycophenolate mofetil (unii: 9242ecw6r0) (mycophenolic acid - unii:hu9dx48n0t) - mycophenolate mofetil 250 mg - mycophenolate mofetil (mmf) is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see clinical studies ( 14.1)] , heart [see clinical studies ( 14.2)] or liver transplants [see clinical studies ( 14.3)] , in combination with other immunosuppressants . allergic reactions to mycophenolate mofetil have been observed; therefore, mycophenolate mofetil is contraindicated in patients with a hypersensitivity to mycophenolate mofetil (mmf), mycophenolic acid (mpa) or any component of the drug product. pregnancy exposure registry: there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to mycophenolate during pregnancy and those becoming pregnant within 6 weeks of discontinuing mycophenolate mofetil treatment. to report a pregnancy or obtain information about the registry, visit www.mycophenolaterems.com or call 1-800-617-8191. risk summary: use of mycophenolate mofetil (mmf) during pregnancy is asso

美国 - 英文 - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 20 mg - furosemide is indicated in adults and pediatric patients for the treatment of edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. furosemide is particularly useful when an agent with greater diuretic potential is desired. oral furosemide may be used in adults for the treatment of hypertension alone or in combination with other antihypertensive agents. hypertensive patients who cannot be adequately controlled with thiazides will probably also not be adequately controlled with furosemide alone. furosemide is contraindicated in patients with anuria and in patients with a history of hypersensitivity to furosemide.

美国 - 英文 - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - ramipril (unii: l35jn3i7sj) (ramiprilat - unii:6n5u4qfc3g) - ramipril 1.25 mg - ramipril is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms

美国 - 英文 - NLM (National Library of Medicine)

hikma pharmaceuticals usa inc. - desvenlafaxine succinate (unii: zb22enf0xr) (desvenlafaxine - unii:ng99554anw) - desvenlafaxine 25 mg - desvenlafaxine is indicated for the treatment of adults with major depressive disorder (mdd) [see clinical studies (14)]. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antidepressants during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for antidepressants at 1-844-405-6185. risk summary based on data from published observational studies, exposure to snris, particularly in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage [see warnings and precautions (5.4) and clinical considerations]. there are no published studies on desvenlafaxine in pregnant women; however published epidemiologic studies of pregnant women exposed to venlafaxine, the parent compound, have not reported a clear association with adverse developmental outcomes (see data ). there are risks associated with untreated depression in pregnancy a

美国 - 英文 - NLM (National Library of Medicine)

kmart corporation - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m) - miconazole nitrate 2 g in 100 g - vaginal antifungal

美国 - 英文 - NLM (National Library of Medicine)

dza brands llc - miconazole nitrate (unii: vw4h1cyw1k) (miconazole - unii:7nno0d7s5m) - miconazole nitrate 2 g in 100 g - vaginal antifungal